TY - JOUR AU - Walboomers, J. M. AU - Jacobs, M. V. AU - Manos, M. M. AU - Bosch, F. X. AU - Kummer, J. A. AU - Shah, K. V. PY - 1999 DA - 1999// TI - Human papillomavirus is a necessary cause of invasive cervical cancer worldwide JO - J Pathol VL - 189 UR - https://doi.org/3.0.CO;2-F DO - 3.0.CO;2-F ID - Walboomers1999 ER - TY - JOUR AU - Muñoz, N. AU - Bosch, F. X. AU - Sanjose, S. AU - Herrero, R. AU - Castellsague, X. AU - Shah, K. V. PY - 2003 DA - 2003// TI - Epidemiologic classification of human papillomavirus types associated with cervical cancer JO - N Engl J Med VL - 348 UR - https://doi.org/10.1056/NEJMoa021641 DO - 10.1056/NEJMoa021641 ID - Muñoz2003 ER - TY - JOUR AU - Arbyn, M. AU - Ronco, G. AU - Anttila, A. AU - Meijer, C. J. L. M. AU - Poljak, M. AU - Ogilvie, G. PY - 2012 DA - 2012// TI - Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer JO - Vaccine VL - 30 UR - https://doi.org/10.1016/j.vaccine.2012.06.095 DO - 10.1016/j.vaccine.2012.06.095 ID - Arbyn2012 ER - TY - JOUR AU - Gage, J. C. AU - Schiffman, M. AU - Katki, H. A. AU - Castle, P. E. AU - Fetterman, B. AU - Wentzensen, N. PY - 2014 DA - 2014// TI - Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test JO - J Natl Cancer Inst VL - 106 UR - https://doi.org/10.1093/jnci/dju153 DO - 10.1093/jnci/dju153 ID - Gage2014 ER - TY - JOUR AU - Ronco, G. AU - Dillner, J. AU - Elfström, K. M. AU - Tunesi, S. AU - Snijders, P. J. F. AU - Arbyn, M. PY - 2013 DA - 2013// TI - Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials JO - Lancet VL - 383 UR - https://doi.org/10.1016/S0140-6736(13)62218-7 DO - 10.1016/S0140-6736(13)62218-7 ID - Ronco2013 ER - TY - JOUR AU - Vink, M. A. AU - Bogaards, J. A. AU - Meijer, C. J. L. M. AU - Berkhof, J. PY - 2015 DA - 2015// TI - Primary human papillomavirus DNA screening for cervical cancer prevention: can the screening interval be safely extended? JO - Int J Cancer VL - 137 UR - https://doi.org/10.1002/ijc.29381 DO - 10.1002/ijc.29381 ID - Vink2015 ER - TY - JOUR AU - Cuzick, J. AU - Cadman, L. AU - Mesher, D. AU - Austin, J. AU - Ashdown-Barr, L. AU - Ho, L. PY - 2013 DA - 2013// TI - Comparing the performance of six human papillomavirus tests in a screening population JO - Br J Cancer VL - 108 UR - https://doi.org/10.1038/bjc.2013.22 DO - 10.1038/bjc.2013.22 ID - Cuzick2013 ER - TY - JOUR AU - Muñoz, N. AU - Bosch, F. X. AU - Castellsagué, X. AU - Díaz, M. AU - Sanjose, S. AU - Hammouda, D. PY - 2004 DA - 2004// TI - Against which human papillomavirus types shall we vaccinate and screen? The international perspective JO - Int J Cancer VL - 111 UR - https://doi.org/10.1002/ijc.20244 DO - 10.1002/ijc.20244 ID - Muñoz2004 ER - TY - JOUR AU - Castle, P. E. AU - Stoler, M. H. AU - Wright, T. C. AU - Sharma, A. AU - Wright, T. L. AU - Behrens, C. M. PY - 2011 DA - 2011// TI - Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study JO - Lancet Oncol VL - 12 UR - https://doi.org/10.1016/S1470-2045(11)70188-7 DO - 10.1016/S1470-2045(11)70188-7 ID - Castle2011 ER - TY - JOUR AU - Cox, J. T. AU - Castle, P. E. AU - Behrens, C. M. AU - Sharma, A. AU - Wright, T. C. AU - Cuzick, J. PY - 2013 DA - 2013// TI - Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV study JO - Am J Obstet Gynecol VL - 208 UR - https://doi.org/10.1016/j.ajog.2012.11.020 DO - 10.1016/j.ajog.2012.11.020 ID - Cox2013 ER - TY - JOUR AU - Rositch, A. F. AU - Koshiol, J. AU - Hudgens, M. G. AU - Razzaghi, H. AU - Backes, D. M. AU - Pimenta, J. M. PY - 2013 DA - 2013// TI - Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis JO - Int J Cancer VL - 133 UR - https://doi.org/10.1002/ijc.27828 DO - 10.1002/ijc.27828 ID - Rositch2013 ER - TY - JOUR AU - Saslow, D. AU - Solomon, D. AU - Lawson, H. W. AU - Killackey, M. AU - Kulasingam, S. L. AU - Cain, J. PY - 2012 DA - 2012// TI - American Cancer Society, American Society for Colposcopy and Cervical Pathology and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer JO - Am J Clin Pathol VL - 137 UR - https://doi.org/10.1309/AJCPTGD94EVRSJCG DO - 10.1309/AJCPTGD94EVRSJCG ID - Saslow2012 ER - TY - JOUR AU - Kyrgiou, M. AU - Koliopoulos, G. AU - Martin-Hirsch, P. AU - Arbyn, M. AU - Prendiville, W. AU - Paraskevaidis, E. PY - 2006 DA - 2006// TI - Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis JO - Lancet VL - 367 UR - https://doi.org/10.1016/S0140-6736(06)68181-6 DO - 10.1016/S0140-6736(06)68181-6 ID - Kyrgiou2006 ER - TY - JOUR AU - Castanon, A. AU - Landy, R. AU - Brocklehurst, P. AU - Evans, H. AU - Peebles, D. AU - Singh, N. PY - 2014 DA - 2014// TI - Risk of preterm delivery with increasing depth of excision for cervical intraepithelial neoplasia in England: nested case–control study JO - BMJ VL - 349 UR - https://doi.org/10.1136/bmj.g6223 DO - 10.1136/bmj.g6223 ID - Castanon2014 ER - TY - JOUR AU - Ikenberg, H. AU - Bergeron, C. AU - Schmidt, D. AU - Griesser, H. AU - Alameda, F. AU - Angeloni, C. PY - 2013 DA - 2013// TI - Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study JO - J Natl Cancer Inst VL - 105 UR - https://doi.org/10.1093/jnci/djt235 DO - 10.1093/jnci/djt235 ID - Ikenberg2013 ER - TY - JOUR AU - Snellenberg, S. AU - Strooper, L. M. AU - Hesselink, A. AU - Meijer, C. AU - Snijders, P. AU - Heideman, D. PY - 2012 DA - 2012// TI - Development of a multiplex methylation-specific PCR as candidate triage test for women with an HPV-positive cervical scrape JO - BMC Cancer VL - 12 UR - https://doi.org/10.1186/1471-2407-12-551 DO - 10.1186/1471-2407-12-551 ID - Snellenberg2012 ER - TY - JOUR AU - Brentnall, A. R. AU - Vasiljević, N. AU - Scibior-Bentkowska, D. AU - Cadman, L. AU - Austin, J. AU - Szarewski, A. PY - 2014 DA - 2014// TI - A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes JO - Int J Cancer VL - 135 UR - https://doi.org/10.1002/ijc.28790 DO - 10.1002/ijc.28790 ID - Brentnall2014 ER - TY - JOUR AU - Ogilvie, G. AU - Niekerk, D. AU - Krajden, M. AU - Martin, R. AU - Ehlen, T. AU - Ceballos, K. PY - 2010 DA - 2010// TI - A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial) JO - BMC Cancer VL - 10 UR - https://doi.org/10.1186/1471-2407-10-111 DO - 10.1186/1471-2407-10-111 ID - Ogilvie2010 ER - TY - STD TI - Cunningham M. More than Just the Kappa Coefficient: A Program to Fully Characterize Inter-Rater Reliability between Two Raters. SAS Global Forum 2009. Available from http://support.sas.com/resources/papers/proceedings09/242-2009.pdf. Accessed April 27, 2015. UR - http://support.sas.com/resources/papers/proceedings09/242-2009.pdf ID - ref19 ER - TY - JOUR AU - Kitchener, H. C. AU - Almonte, M. AU - Thomson, C. AU - Wheeler, P. AU - Sargent, A. AU - Stoykova, B. PY - 2009 DA - 2009// TI - HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial JO - Lancet Oncol VL - 10 UR - https://doi.org/10.1016/S1470-2045(09)70156-1 DO - 10.1016/S1470-2045(09)70156-1 ID - Kitchener2009 ER - TY - JOUR AU - Rijkaart, D. C. AU - Berkhof, J. AU - Rozendaal, L. AU - Kemenade, F. J. AU - Bulkmans, N. W. J. AU - Heideman, D. A. M. PY - 2012 DA - 2012// TI - Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial JO - Lancet Oncol VL - 13 UR - https://doi.org/10.1016/S1470-2045(11)70296-0 DO - 10.1016/S1470-2045(11)70296-0 ID - Rijkaart2012 ER - TY - JOUR AU - Castle, P. E. AU - Cox, J. T. AU - Jeronimo, J. AU - Solomon, D. AU - Wheeler, C. M. AU - Gravitt, P. E. PY - 2008 DA - 2008// TI - An analysis of high-risk human papillomavirus DNA-negative cervical precancers in the ASCUS-LSIL triage study (ALTS) JO - Obstet Gynecol VL - 111 UR - https://doi.org/10.1097/AOG.0b013e318168460b DO - 10.1097/AOG.0b013e318168460b ID - Castle2008 ER - TY - JOUR AU - Bouchard-Fortier, G. AU - Hajifathalian, K. AU - McKnight, M. D. AU - Zacharias, D. G. AU - Gonzalez-Gonzalez, L. A. PY - 2014 DA - 2014// TI - Co-testing for detection of high-grade cervical intraepithelial neoplasia and cancer compared with cytology alone: a meta-analysis of randomized controlled trials JO - J Public Health VL - 36 UR - https://doi.org/10.1093/pubmed/fdt057 DO - 10.1093/pubmed/fdt057 ID - Bouchard-Fortier2014 ER - TY - JOUR AU - Blatt, A. J. AU - Kennedy, R. AU - Luff, R. D. AU - Austin, R. M. AU - Rabin, D. S. PY - 2015 DA - 2015// TI - Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices JO - Cancer Cytopathol VL - 123 UR - https://doi.org/10.1002/cncy.21544 DO - 10.1002/cncy.21544 ID - Blatt2015 ER - TY - JOUR AU - Elfström, K. M. AU - Smelov, V. AU - Johansson, A. L. V. AU - Eklund, C. AU - Nauclér, P. AU - Arnheim-Dahlström, L. PY - 2014 DA - 2014// TI - Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial JO - BMJ VL - 348 UR - https://doi.org/10.1136/bmj.g130 DO - 10.1136/bmj.g130 ID - Elfström2014 ER - TY - JOUR AU - Wright, T. C. AU - Stoler, M. H. AU - Behrens, C. M. AU - Sharma, A. AU - Zhang, G. AU - Wright, T. L. PY - 2015 DA - 2015// TI - Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test JO - Gynecol Oncol VL - 136 UR - https://doi.org/10.1016/j.ygyno.2014.11.076 DO - 10.1016/j.ygyno.2014.11.076 ID - Wright2015 ER - TY - JOUR AU - Ogilvie, G. S. AU - Krajden, M. AU - Niekerk, D. J. AU - Martin, R. E. AU - Ehlen, T. G. AU - Ceballos, K. PY - 2012 DA - 2012// TI - Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial - the HPV FOCAL Study JO - Br J Cancer VL - 107 UR - https://doi.org/10.1038/bjc.2012.489 DO - 10.1038/bjc.2012.489 ID - Ogilvie2012 ER - TY - STD TI - British Columbia Cancer Agency. Cervical Cancer Screening Program 2012 Annual Report. Available from http://www.screeningbc.ca/NR/rdonlyres/F2D89BB9-3B33-4DBD-BE76-975A220B0C7B/69596/CCSPAnnualReport2012PrintVersion.pdf. Accessed April 27, 2015. UR - http://www.screeningbc.ca/NR/rdonlyres/F2D89BB9-3B33-4DBD-BE76-975A220B0C7B/69596/CCSPAnnualReport2012PrintVersion.pdf ID - ref28 ER - TY - JOUR AU - Wright, T. C. AU - Stoler, M. H. AU - Behrens, C. M. AU - Apple, R. AU - Derion, T. AU - Wright, T. L. PY - 2011 DA - 2011// TI - The ATHENA human papillomavirus study: design, methods, and baseline results JO - Am J Obstet Gynecol VL - 46 ID - Wright2011 ER - TY - JOUR AU - Ogilvie, G. S. AU - Cook, D. A. AU - Taylor, D. L. AU - Rank, C. AU - Kan, L. AU - Yu, A. PY - 2013 DA - 2013// TI - Population-based evaluation of type-specific HPV prevalence among women in British Columbia, Canada JO - Vaccine VL - 31 UR - https://doi.org/10.1016/j.vaccine.2012.09.085 DO - 10.1016/j.vaccine.2012.09.085 ID - Ogilvie2013 ER - TY - JOUR AU - Cubie, H. A. AU - Cuschieri, K. PY - 2013 DA - 2013// TI - Understanding HPV tests and their appropriate applications JO - Cytopathology VL - 24 ID - Cubie2013 ER - TY - JOUR AU - Bulkmans, N. W. J. AU - Berkhof, J. AU - Bulk, S. AU - Bleeker, M. C. G. AU - Kemenade, F. J. AU - Rozendaal, L. PY - 2007 DA - 2007// TI - High-risk HPV type-specific clearance rates in cervical screening JO - Br J Cancer VL - 96 ID - Bulkmans2007 ER - TY - JOUR AU - Naucler, P. AU - Ryd, W. AU - Törnberg, S. AU - Strand, A. AU - Wadell, G. AU - Elfgren, K. PY - 2009 DA - 2009// TI - Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening JO - J Natl Cancer Inst VL - 101 UR - https://doi.org/10.1093/jnci/djn444 DO - 10.1093/jnci/djn444 ID - Naucler2009 ER - TY - JOUR AU - Rodríguez, A. C. AU - Schiffman, M. AU - Herrero, R. AU - Wacholder, S. AU - Hildesheim, A. AU - Castle, P. E. PY - 2008 DA - 2008// TI - Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections JO - J Natl Cancer Inst VL - 100 UR - https://doi.org/10.1093/jnci/djn044 DO - 10.1093/jnci/djn044 ID - Rodríguez2008 ER - TY - JOUR AU - Castle, P. E. AU - Hunt, W. C. AU - Langsfeld, E. AU - Wheeler, C. M. AU - Committee, N. M. H. P. R. PY - 2014 DA - 2014// TI - Three-year risk of cervical precancer and cancer after the detection of low-risk human papillomavirus genotypes targeted by a commercial test JO - Obstet Gynecol VL - 123 UR - https://doi.org/10.1097/AOG.0000000000000013 DO - 10.1097/AOG.0000000000000013 ID - Castle2014 ER - TY - JOUR AU - Smelov, V. AU - Elfström, K. M. AU - Johansson, A. L. V. AU - Eklund, C. AU - Naucler, P. AU - Arnheim-Dahlström, L. PY - 2015 DA - 2015// TI - Long-term HPV type-specific risks of high-grade cervical intraepithelial lesions: a 14-year follow-up of a randomized primary HPV screening trial JO - Int J Cancer VL - 136 UR - https://doi.org/10.1002/ijc.29085 DO - 10.1002/ijc.29085 ID - Smelov2015 ER -